Urge your members of Congress to support continued medical research funding
ASH, the world's
largest professional society concerned with the causes and treatments of blood
disorders, regularly issues press releases highlighting clinical and research
advances announced at the ASH annual meeting and published
in Blood, as well as releases and statements on breaking policy news
affecting the field of hematology.
Need to speak with an expert? Complete our Request An Expert form.
To be added to ASH's press release distribution list, contact Stephen Fitzmaurice at firstname.lastname@example.org.
In four clinical trials being presented today during the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta, researchers report promising results suggesting patients with blood disorders and several types of cancer will soon have significantly expanded options for treatment.
The American Society of Hematology will recognize three Choosing Wisely® Champions, practitioners working to tackle overuse of hematology tests and treatments, today at its 59th annual meeting in Atlanta.
In the first comprehensive analysis of clinical trial enrollment among older adults with blood cancers, researchers from the U.S. Food and Drug Administration found significant gaps in participation among those aged 75 and older when considered against the incidence of these malignancies in this age group, according to research being presented today during the 59th American Society of Hematology Annual Meeting and Exposition in Atlanta.
Urge your members of Congress to support continued medical research funding.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology